Lifevantage EBITDA Margin 2010-2024 | LFVN

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Lifevantage (LFVN) over the last 10 years. The current EBITDA margin for Lifevantage as of December 31, 2024 is .
Lifevantage EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-12-31 $0.21B $0.01B 6.60%
2024-09-30 $0.20B $0.01B 5.10%
2024-06-30 $0.20B $0.01B 4.50%
2024-03-31 $0.21B $0.01B 4.39%
2023-12-31 $0.21B $0.01B 3.79%
2023-09-30 $0.21B $0.01B 3.76%
2023-06-30 $0.21B $0.01B 3.74%
2023-03-31 $0.21B $0.01B 2.37%
2022-12-31 $0.21B $0.01B 2.90%
2022-09-30 $0.21B $0.01B 3.41%
2022-06-30 $0.21B $0.01B 5.34%
2022-03-31 $0.21B $0.02B 8.57%
2021-12-31 $0.21B $0.02B 8.49%
2021-09-30 $0.22B $0.02B 10.96%
2021-06-30 $0.22B $0.02B 10.86%
2021-03-31 $0.23B $0.02B 10.67%
2020-12-31 $0.23B $0.03B 10.92%
2020-09-30 $0.23B $0.02B 9.96%
2020-06-30 $0.23B $0.02B 9.05%
2020-03-31 $0.23B $0.02B 8.30%
2019-12-31 $0.23B $0.02B 7.86%
2019-09-30 $0.23B $0.01B 6.19%
2019-06-30 $0.23B $0.01B 5.31%
2019-03-31 $0.22B $0.01B 4.91%
2018-12-31 $0.22B $0.01B 5.02%
2018-09-30 $0.21B $0.01B 6.19%
2018-06-30 $0.20B $0.01B 6.40%
2018-03-31 $0.20B $0.01B 5.00%
2017-12-31 $0.19B $0.01B 4.12%
2017-09-30 $0.19B $0.01B 3.09%
2017-06-30 $0.20B $0.01B 3.00%
2017-03-31 $0.20B $0.01B 4.46%
2016-12-31 $0.21B $0.01B 5.63%
2016-09-30 $0.22B $0.02B 6.94%
2016-06-30 $0.21B $0.02B 7.77%
2016-03-31 $0.20B $0.01B 6.57%
2015-12-31 $0.19B $0.01B 5.88%
2015-09-30 $0.18B $0.01B 6.01%
2015-06-30 $0.19B $0.02B 8.42%
2015-03-31 $0.20B $0.02B 9.45%
2014-12-31 $0.21B $0.02B 10.43%
2014-09-30 $0.22B $0.02B 11.16%
2014-06-30 $0.21B $0.02B 10.28%
2014-03-31 $0.21B $0.02B 8.57%
2013-12-31 $0.21B $0.02B 8.29%
2013-09-30 $0.21B $0.01B 5.83%
2013-06-30 $0.21B $0.01B 6.25%
2013-03-31 $0.20B $0.02B 9.95%
2012-12-31 $0.19B $0.02B 12.30%
2012-09-30 $0.16B $0.03B 16.35%
2012-06-30 $0.13B $0.02B 18.25%
2012-03-31 $0.10B $0.02B 17.71%
2011-12-31 $0.07B $0.01B 12.86%
2011-09-30 $0.05B $0.01B 13.46%
2011-06-30 $0.04B $0.00B 7.89%
2011-03-31 $0.03B 0 0.00%
2010-12-31 $0.02B 0 0.00%
2010-09-30 $0.02B $0.00B -26.67%
2010-06-30 $0.01B $-0.01B -63.64%
2010-03-31 $0.01B $-0.01B -122.22%
2009-12-31 $0.01B $-0.01B -171.43%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.155B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.641B 24.25
Becton Dickinson (BDX) United States $59.276B 14.84
Cardinal Health (CAH) United States $33.781B 18.09
Labcorp (LH) United States $20.116B 16.32
Straumann Holding AG (SAUHY) Switzerland $19.852B 0.00
Cooper (COO) United States $16.444B 21.81
West Pharmaceutical Services (WST) United States $15.336B 32.15
Align Technology (ALGN) United States $13.013B 25.21
Henry Schein (HSIC) United States $8.105B 13.96
Merit Medical Systems (MMSI) United States $5.600B 27.07
DENTSPLY SIRONA (XRAY) United States $2.780B 8.35
CONMED (CNMD) United States $1.583B 12.30
STAAR Surgical (STAA) United States $0.918B 0.00
Pro-Dex (PDEX) United States $0.217B 33.03